|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 39/35 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 39/39 | (2006.01) |
| (11) | Number of the document | 2484375 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12153249.3 |
| Date of filing the European patent application | 2007-09-26 | |
| (97) | Date of publication of the European application | 2012-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-23 |
| (46) | Date of publication of the claims translation | 2018-07-10 |
| (30) | Number | Date | Country code |
| 847404 P | 2006-09-26 | US |
| (72) |
Reed, Steven, G., US
Carter, Darrick, US
|
| (73) |
Infectious Disease Research Institute,
1616 Eastlake Ave. E Suite 400, Seattle, WA 98102,
US
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Vakcinos kompozicija, turinti sintetinio adjuvanto |
| Vaccine composition containing synthetic adjuvant |
| Payment date | Validity (years) | Amount | |
| 2025-08-25 | 19 | 347.00 EUR |
| 2026-09-26 |